2020
DOI: 10.21608/mjmr.2022.220333
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of Serum urokinase Plasminogen Activator Receptor (SuPAR) Levels in Childhood Epilepsy

Abstract: Background: Epilepsy is the most common serious neurological disorder worldwide. Epilepsy is a chronic brain disorder affecting 3.5-5/1000 children in developed countries with 41-187/100,000 cases reported every year. It increases the incidence of complications and mortality. Generalized convulsive seizures (GCSs) are associated with high demands on the cardiovascular system, thereby facilitating cardiac complications. SuPAR is an emerging marker of cardiovascular disease burden. Objectives: Aim of the study: … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 8 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?